T Lymphocyte Potential Marks the Emergence of Definitive Hematopoietic Progenitors in Human Pluripotent Stem Cell Differentiation Cultures

Cell Reports

Volumn 2, Issue 6, 2012, Pages 1722-1735

  Kennedy, Marion ^a   Awong, Geneve ^a,b   Sturgeon, Christopher M ^a   Ditadi, Andrea ^a   LaMotte Mohs, Ross ^b,c   Zúñiga Pflücker, Juan Carlos ^b   Keller, Gordon ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c Wellstat Therapeutics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; CD34 ANTIGEN; MORPHOGEN; PROTEIN NODAL; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX1; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM; ERYTHROID CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOID PROGENITOR CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; PLURIPOTENT STEM CELLS; PRECURSOR CELLS, T-LYMPHOID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84871698997     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.11.003     Document Type: Article

References (56)

1. Andersson L.C., von Willebrand E., Jokinen M., Karhi K.K., Gahmberg C.G. Glycophorin A as an erythroid marker in normal and malignant hematopoiesis. Haematol. Blood Transfus. 1981, 26:338-344.
2. Awong G., Herer E., Surh C.D., Dick J.E., La Motte-Mohs R.N., Zúñiga-Pflücker J.C. Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood 2009, 114:972-982.
3. Bertrand J.Y., Giroux S., Golub R., Klaine M., Jalil A., Boucontet L., Godin I., Cumano A. Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their site of origin. Proc. Natl. Acad. Sci. USA 2005, 102:134-139.
4. Chadwick K., Wang L., Li L., Menendez P., Murdoch B., Rouleau A., Bhatia M. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
5. Choi K.D., Vodyanik M.A., Togarrati P.P., Suknuntha K., Kumar A., Samarjeet F., Probasco M.D., Tian S., Stewart R., Thomson J.A., et al. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep. 2012, 2:553-567.
6. Conlon F.L., Lyons K.M., Takaesu N., Barth K.S., Kispert A., Herrmann B., Robertson E.J. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 1994, 120:1919-1928.
7. Davis R.P., Ng E.S., Costa M., Mossman A.K., Sourris K., Elefanty A.G., Stanley E.G. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 2008, 111:1876-1884.
8. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 2010, 11:585-593.
9. Dzierzak E., Speck N.A. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat. Immunol. 2008, 9:129-136.
10. Feugier P., Li N., Jo D.Y., Shieh J.H., MacKenzie K.L., Lesesve J.F., Latger-Cannard V., Bensoussan D., Crystal R.G., Rafii S., et al. Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro. Stem Cells Dev. 2005, 14:505-516.
11. Funaro A., Spagnoli G.C., Ausiello C.M., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 1990, 145:2390-2396.
12. Galic Z., Kitchen S.G., Kacena A., Subramanian A., Burke B., Cortado R., Zack J.A. T lineage differentiation from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2006, 103:11742-11747.
13. Hong S.H., Lee J.H., Lee J.B., Ji J., Bhatia M. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis. J. Cell Sci. 2011, 124:1445-1452.
14. Inman G.J., Nicolás F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002, 62:65-74.
15. Irion S., Clarke R.L., Luche H., Kim I., Morrison S.J., Fehling H.J., Keller G.M. Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells. Development 2010, 137:2829-2839.
16. Ivanovs A., Rybtsov S., Welch L., Anderson R.A., Turner M.L., Medvinsky A. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J. Exp. Med. 2011, 208:2417-2427.
17. Jackson S.A., Schiesser J., Stanley E.G., Elefanty A.G. Differentiating embryonic stem cells pass through 'temporal windows' that mark responsiveness to exogenous and paracrine mesendoderm inducing signals. PLoS One 2010, 5:e10706.
18. June C.H., Ledbetter J.A., Linsley P.S., Thompson C.B. Role of the CD28 receptor in T-cell activation. Immunol. Today 1990, 11:211-216.
19. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2001, 98:10716-10721.
20. Kennedy M., D'Souza S.L., Lynch-Kattman M., Schwantz S., Keller G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007, 109:2679-2687.
21. Klimchenko O., Mori M., Distefano A., Langlois T., Larbret F., Lecluse Y., Feraud O., Vainchenker W., Norol F., Debili N. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 2009, 114:1506-1517.
22. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., Young H., Richardson M., Smart N.G., Cunningham J., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
23. Labastie M.C., Cortés F., Roméo P.H., Dulac C., Péault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood 1998, 92:3624-3635.
24. La Motte-Mohs R.N., Herer E., Zúñiga-Pflücker J.C. Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 2005, 105:1431-1439.
25. Ledran M.H., Krassowska A., Armstrong L., Dimmick I., Renström J., Lang R., Yung S., Santibanez-Coref M., Dzierzak E., Stojkovic M., et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 2008, 3:85-98.
26. Lu M., Kardel M.D., O'Connor M.D., Eaves C.J. Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp. Hematol. 2009, 37:924-936.
27. Marshall C.J., Moore R.L., Thorogood P., Brickell P.M., Kinnon C., Thrasher A.J. Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer. Dev. Dyn. 1999, 215:139-147.
28. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
29. Ng E.S., Azzola L., Sourris K., Robb L., Stanley E.G., Elefanty A.G. The primitive streak gene Mixl1 is required for efficient haematopoiesis and BMP4-induced ventral mesoderm patterning in differentiating ES cells. Development 2005, 132:873-884.
30. Nostro M.C., Cheng X., Keller G.M., Gadue P. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2008, 2:60-71.
31. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisica I., Dick J.E. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
32. Oberlin E., Tavian M., Blazsek I., Péault B. Blood-forming potential of vascular endothelium in the human embryo. Development 2002, 129:4147-4157.
33. Palis J., Malik J., McGrath K.E., Kingsley P.D. Primitive erythropoiesis in the mammalian embryo. Int. J. Dev. Biol. 2010, 54:1011-1018.
34. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
35. Pearson S., Sroczynska P., Lacaud G., Kouskoff V. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 2008, 135:1525-1535.
36. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988, 71:831-843.
37. Pick M., Azzola L., Mossman A., Stanley E.G., Elefanty A.G. Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 2007, 25:2206-2214.
38. Rhodes K.E., Gekas C., Wang Y., Lux C.T., Francis C.S., Chan D.N., Conway S., Orkin S.H., Yoder M.C., Mikkola H.K. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2008, 2:252-263.
39. Schmitt T.M., de Pooter R.F., Gronski M.A., Cho S.K., Ohashi P.S., Zúñiga-Pflücker J.C. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat. Immunol. 2004, 5:410-417.
40. Schuh K., Twardzik T., Kneitz B., Heyer J., Schimpl A., Serfling E. The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells. J. Exp. Med. 1998, 188:1369-1373.
41. Sumi T., Tsuneyoshi N., Nakatsuji N., Suemori H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development 2008, 135:2969-2979.
42. Taoudi S., Medvinsky A. Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta. Proc. Natl. Acad. Sci. USA 2007, 104:9399-9403.
43. Tavian M., Robin C., Coulombel L., Péault B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 2001, 15:487-495.
44. Tavian M., Biasch K., Sinka L., Vallet J., Péault B. Embryonic origin of human hematopoiesis. Int. J. Dev. Biol. 2010, 54:1061-1065.
45. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
46. Tian X., Woll P.S., Morris J.K., Linehan J.L., Kaufman D.S. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 2006, 24:1370-1380.
47. Timmermans F., Velghe I., Vanwalleghem L., De Smedt M., Van Coppernolle S., Taghon T., Moore H.D., Leclercq G., Langerak A.W., Kerre T., et al. Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J. Immunol. 2009, 182:6879-6888.
48. Vijayaragavan K., Szabo E., Bossé M., Ramos-Mejia V., Moon R.T., Bhatia M. Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 2009, 4:248-262.
49. Vodyanik M.A., Thomson J.A., Slukvin I.I. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006, 108:2095-2105.
50. Wang L., Li L., Shojaei F., Levac K., Cerdan C., Menendez P., Martin T., Rouleau A., Bhatia M. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004, 21:31-41.
51. Wang L., Menendez P., Shojaei F., Li L., Mazurier F., Dick J.E., Cerdan C., Levac K., Bhatia M. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med. 2005, 201:1603-1614.
52. Yokomizo T., Dzierzak E. Three-dimensional cartography of hematopoietic clusters in the vasculature of whole mouse embryos. Development 2010, 137:3651-3661.
53. Yoshimoto M., Montecino-Rodriguez E., Ferkowicz M.J., Porayette P., Shelley W.C., Conway S.J., Dorshkind K., Yoder M.C. Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential. Proc. Natl. Acad. Sci. USA 2011, 108:1468-1473.
54. Yoshimoto M., Porayette P., Glosson N.L., Conway S.J., Carlesso N., Cardoso A.A., Kaplan M.H., Yoder M.C. Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence. Blood 2012, 119:5706-5714.
55. Yu C., Liu Y., Miao Z., Yin M., Lu W., Lv Y., Ding M., Deng H. Retinoic acid enhances the generation of hematopoietic progenitors from human embryonic stem cell-derived hemato-vascular precursors. Blood 2010, 116:4786-4794.
56. Zambidis E.T., Peault B., Park T.S., Bunz F., Civin C.I. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005, 106:860-870.